Locate your nearest distributor

Text search:
Forgot password?

News Archive

Biohit Oyj starts two clinical trials with Acetium® capsule for prevention of migraine-type headache

29.04.2014 16:30

Biohit Oyj initiates two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule in novel clinical indications. The purpose of the trial is to assess the effect of Acetium® capsule in prevention of headache attacks among patients suffering from migraine or cluster/Horton headache. Both studies will be conducted as multi-center clinical trials in collaboration with Terveystalo Oy and Aava Medical Center altogether in six cities in Finland.
Biohit Oyj Stock Exchange Release April 29, 2014 a 4 pm local time (EEST) (opens in a new window)